Cargando…
Salvage Treatment for Progressive Brain Metastases in Breast Cancer
SIMPLE SUMMARY: Thirty percent of patients with human epidermal growth factor receptor 2-positive breast cancer and triple-negative breast cancer, and 15% of patients with the remaining subtypes of breast cancer will develop brain metastases. Available treatment methods include surgery and radiother...
Autores principales: | Spałek, Mateusz Jacek, Mandat, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870695/ https://www.ncbi.nlm.nih.gov/pubmed/35205844 http://dx.doi.org/10.3390/cancers14041096 |
Ejemplares similares
-
The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022) -
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012) -
Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
por: Duchnowska, Renata, et al.
Publicado: (2016) -
Methods and results of local treatment of brain metastases in patients with breast cancer
por: Szadurska, Agnieszka, et al.
Publicado: (2017) -
Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease
por: Tykocki, Tomasz, et al.
Publicado: (2011)